Background The relationship between platelet reactivity and long-term clinical outcomes
remains controversial. The present prospective study was designed to explore the …

Background Patients with acute coronary syndromes (ACS) who undergo stent implantation
have higher on–treatment platelet reactivity (HPR), which has been associated with …

Background: High residual platelet reactivity (HRPR) during dual antiplatelet therapy (DAPT)
may impact clinical outcomes following percutaneous coronary interventions (PCI) …

Patients at high risk of thrombotic events after percutaneous coronary intervention (PCI) may
potentially benefit from intensified antiplatelet therapy. However, more potent antiplatelet …

BACKGROUND: The inhibitory response to clopidogrel varies widely among individuals.
Data suggest that patients with high residual platelet reactivity despite clopidogrel therapy …

Aims The aim of this study was to determine whether platelet reactivity on clopidogrel
therapy, as measured by a point-of-care platelet function assay, is associated with …

Background The long-term prognostic implication of platelet reactivity after percutaneous
coronary intervention (PCI) is not clearly known. Objectives The impacts of platelet reactivity …

Objectives: The authors sought to investigate the association between P2Y12 reaction units
(PRU) and the risk of ischemic stroke (IS) after successful coronary drug-eluting stents (DES) …

Aims Although platelet reactivity during P2Y12-inhibitors is associated with stent thrombosis
(ST) and bleeding, standardized and clinically validated thresholds for accurate risk …

Stent thrombosis (ST) is a fatal complication after percutaneous coronary intervention (PCI).
The association between P2Y12 reaction unit (PRU) level and stent thrombosis occurrence …